Loading…
← Back to schedule
Panel: CAR-Ts: From Oncology Superstars to Autoimmune Upstarts
Monday September 30, 2024 1:45pm - 2:30pm EDT
CAR-Ts were promised as the next big thing in cancer care, until midway through 2023 the narrative changed. All of a sudden biotechs began announcing a pivot to autoimmune conditions—specifically lupus, the long challenging chronic disease where the body attacks its own tissues. What’s behind this change in direction? In this panel, we’ll explore how biotechs can be successful in this new paradigm, whether they stick to cancer or forge on to autoimmune.

Moderated by: Fierce Editorial Team
Panel Closed
Speakers
avatar for Jennifer Michaelson, Ph.D.

Jennifer Michaelson, Ph.D.

Chief Scientific Officer, Cullinan Therapeutics
Jennifer Michaelson is a biotech executive with 20+ years of industry experience in oncology, immunology, and immune-oncology drug development. Prior to joining Cullinan Therapeutics, Jennifer participated in the launch of Jounce Therapeutics, where she built and led multiple departments... Read More →
avatar for Kristin Yarema, Ph.D.

Kristin Yarema, Ph.D.

President and CEO, Poseida Therapeutics
Dr. Yarema was appointed President and Chief Executive Officer of Poseida and named to the Board of Directors in January 2024. She joined Poseida as President, Cell Therapy in April 2023, bringing extensive biopharmaceutical experience in oncology and allogeneic T cell immunotherapy... Read More →
avatar for Michael Lehmicke

Michael Lehmicke

Senior Vice President, Science and Industry Affairs, Alliance for Regenerative Medicine (ARM)
Mike joined ARM in 2019 as its first Director of Science and Industry Affairs and was subsequently promoted to Senior Director and Vice President, Science and Industry Affairs. He has over 20 years of R&D experience in biomaterials, medical devices, and regenerative medicine. He has... Read More →
avatar for David R. Shook, M.D.

David R. Shook, M.D.

Chief Medical Officer, Nkarta, Inc.
Dr. Shook was appointed Chief Medical Officer in 2023 and leads Nkarta’s global clinical development and regulatory operations. He has more than 10 years of clinical research and development experience and has authored dozens of scientific publications covering areas including the... Read More →
Monday September 30, 2024 1:45pm - 2:30pm EDT
  Track: Early-Stage Development

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link